75
Participants
Start Date
January 24, 2023
Primary Completion Date
May 24, 2023
Study Completion Date
May 24, 2023
Low-dose bitter melon
Subject will receive 1 Insumate bitter melon capsule/d (300 mg) and 1 placebo capsule/d (300 mg)
High-dose bitter melon
Subject will receive 2 Insumate bitter melon capsules/d (300 mg each)
Placebo
Subject will receive 2 placebo capsules/d (300 mg each)
Excellence Medical & Research, Miami Gardens
Health Awareness, Port Saint Lucie
Biofortis, Inc., Addison
Collaborators (1)
Greenyn Biotechnology
UNKNOWN
Midwest Center for Metabolic and Cardiovascular Research
OTHER